American Shared Hospital Services AMS 深 沪
等待开盘 09-23 09:30:00 美东时间
2.45
-0.080
-3.16%
华盛通- 最 高2.54
- 今 开2.54
- 成交量 4015股
- 最 低 2.43
- 昨 收 2.53
- 总市值 1594.95万
- 52周最高 3.59
- 市盈率 静 7.51
- 换手率 0.06%
- 52周最低 2.27
- 委 比 -94.17%
- 总股本 651.00万
- 历史最高 5.04
- 量 比 0.35
- 振 幅 4.35%
- 历史最低 1.16
- 每 手 1
- 风险率 0.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Atomos Limited Director Increases Shareholding
The latest announcement is out from Atomos ( ($AU:AMS) ). Atomos Limited has an...
09-19 10:28
The Brink's declares $0.255 dividend
The Brink's (NYSE:BCO) declares $0.255/share quarterly dividend, in line with previous. Forward yield 0.89% Payable Dec. 1; to shareholders of record Nov. 3; ex-div Nov. 3. The company has now announc...
09-18 13:05
AI点燃的半导体“牛市叙事”再强化! 高盛预言“AI算力+先进封装+EDA”撑起最强主线
博通、甲骨文等AI算力产业链龙头给出AI营收里程碑，市场情绪与基本面同频共振。高盛再添一把火：AI驱动的半导体结构性牛市愈发巩固，半导体板块进入算力+封装+EDA三箭齐发时代，谨慎对待“苹果系RF”。
09-12 18:12
Atomos Director Increases Shareholding
Atomos ( ($AU:AMS) ) just unveiled an update. Atomos Limited announced a change...
09-09 11:27
营收大增35%背后，美迪凯的“专精特新”硬实力
8月21日晚间，国家级专精特新“小巨人”企业——杭州美迪凯光电科技股份有限公司（688079.SH，以下简称“美迪凯”）发布2025年半年度报告：公司实现营业收...
09-05 19:54
Silexion Therapeutics Selects A Contract Research Organization AMS Advanced Medical Services GmbH To Support SIL204 Phase 2/3 Trials Targeting KRAS Cancers, Following 97% Inhibition Rates; Trials Expected To Begin 1H 2026
Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204Phase 2/3 Clinical Trials Expected to Commence in First Half of 2026 Following Q4 2025 and
09-04 21:28
Atomos Unveils FY25 Results and Future Outlook
Atomos ( ($AU:AMS) ) has issued an update. Atomos Limited has released its FY25...
09-01 12:57
Atomos Ltd Announces FY25 Financial Results
Atomos ( ($AU:AMS) ) just unveiled an announcement. Atomos Ltd has released its...
09-01 11:07
Atomos Reports Revenue Decline but Improved EBITDA for FY25
Atomos ( ($AU:AMS) ) has shared an announcement. Atomos Ltd reported a 9% decli...
08-29 20:28
